About iATROS
iATROS is a company based in Munchen (Germany) founded in 2018. It operates as a HealthTech and Subscription Services. iATROS has raised $2.26 million across 1 funding round from investors including Bayern Kapital and High-Tech Gründerfonds. iATROS offers products and services including SmartWatch EKG Befundung, Online Zweitmeinung, and Online Sprechstunde. iATROS operates in a competitive market with competitors including Endotronix, Edwards Lifesciences, CoachCare, BioIntelliSense and Oxehealth, among others.
- Headquarter Munchen, Germany
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Iatros Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.26 M (USD)
in 1 rounds
-
Latest Funding Round
$2.26 M (USD), Seed
Mar 09, 2020
-
Investors
Bayern Kapital
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of iATROS
iATROS offers a comprehensive portfolio of products and services, including SmartWatch EKG Befundung, Online Zweitmeinung, and Online Sprechstunde.
EKG results are evaluated by tele-doctors within minutes.
Second opinions on heart conditions are provided quickly.
Consultations for cardiovascular issues are offered anytime, anywhere.
People of iATROS
Unlock access to complete
Funding Insights of iATROS
iATROS has successfully raised a total of $2.26M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.26 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in iATROS
iATROS has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Bayern Kapital and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
High-tech industries are targeted for investments by Bayern Kapital.
|
Locked | Locked | Locked | |
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked |
Investor details for iATROS
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by iATROS
Investment portfolio details for iATROS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - iATROS
Detailed financials for iATROS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Iatros Comparisons
Peer comparison for iATROS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of iATROS
iATROS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endotronix, Edwards Lifesciences, CoachCare, BioIntelliSense and Oxehealth, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| Locked | Locked | Locked |
Medical devices for structural heart disease are developed and provided.
|
|
| Locked | Locked | Locked |
Remote monitoring platform for tracking patient activity
|
|
| Locked | Locked | Locked |
Vital signs are monitored via a single-use patch and platform.
|
|
| Locked | Locked | Locked |
Contactless patient monitoring is provided for mental health facilities.
|
|
| Locked | Locked | Locked |
Provider of imaging technologies for medical diagnosis and treatments
|
Detailed competitors of iATROS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Iatros
Complete news archive for iATROS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about iATROS
iATROS was founded in 2018 and raised its 1st funding round 2 years after it was founded.
iATROS is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Alexander Leber is the current CEO of iATROS.
iATROS is a funded company, having raised a total of $2.26M across 1 funding round to date.
A digital health platform for cardiovascular care is operated by iATROS. Patients are supported with services like EKG evaluations, second opinions, and online consultations. Tele-monitoring and digital therapy plans are integrated to manage conditions such as hypertension, atrial fibrillation, and heart failure. Collaboration with leading health insurance providers is maintained to ensure accessibility. The platform aims to deliver guideline-compliant and sustainable therapy through comprehensive digital health programs across various regions.
iATROS's top competitors include Endotronix, TestCard and Oxehealth.
iATROS offers SmartWatch EKG Befundung, Online Zweitmeinung, and Online Sprechstunde.
iATROS has 2 investors. Key investors include Bayern Kapital, and High-Tech Gründerfonds.